Search hospitals > Georgia > Atlanta
Emory University Hospital/Winship Cancer Institute
Claim this profileAtlanta, Georgia 30322
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Multiple Myeloma
Conducts research for Pancreatic Cancer
1082 reported clinical trials
100 medical researchers
Summary
Emory University Hospital/Winship Cancer Institute is a medical facility located in Atlanta, Georgia. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Multiple Myeloma, Pancreatic Cancer and other specialties. Emory University Hospital/Winship Cancer Institute is involved with conducting 1,082 clinical trials across 815 conditions. There are 100 research doctors associated with this hospital, such as Jonathan Cohen, MD, Conor Steuer, Ticiana A. Leal, and Olatunji Alese.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
Stage III
Top PIs
Jonathan Cohen, MDJadestone Clinical Research, LLC1 year of reported clinical research
Studies Coronavirus
Studies COVID-19
19 reported clinical trials
31 drugs studied
Conor SteuerEmory University Hospital Midtown1 year of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
38 drugs studied
Ticiana A. LealUniversity of Wisconsin Hospital and Clinics5 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
24 drugs studied
Olatunji AleseEmory University Hospital/Winship Cancer Institute7 years of reported clinical research
Studies Pancreatic Cancer
Studies Colorectal Cancer
17 reported clinical trials
42 drugs studied
Clinical Trials running at Emory University Hospital/Winship Cancer Institute
Lung Cancer
Breast Cancer
Skin Cancer
Prostate Cancer
Multiple Myeloma
Breast cancer
Colorectal Cancer
Ovarian Cancer
Cancer
Brain Tumor
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Emory University Hospital/Winship Cancer Institute?
Emory University Hospital/Winship Cancer Institute is a medical facility located in Atlanta, Georgia. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Multiple Myeloma, Pancreatic Cancer and other specialties. Emory University Hospital/Winship Cancer Institute is involved with conducting 1,082 clinical trials across 815 conditions. There are 100 research doctors associated with this hospital, such as Jonathan Cohen, MD, Conor Steuer, Ticiana A. Leal, and Olatunji Alese.
Where is Emory University Hospital/Winship Cancer Institute located?
**Emory Winship Cancer Institute Location and Parking Information:**
- **Address:** 1365 Clifton Road NE, Building B, Atlanta, Georgia, on the Emory University Hospital campus.
- **Directions:** From I-85, take the North Avenue exit (Exit #249D), turn left on North Avenue, right onto Peachtree Street, and then right into the Visitor Parking Deck after passing Linden Avenue.
- **Parking:** Valet parking and drop-off at 36 Linden Avenue NE. Onsite self-parking at 575 W Peachtree Street NW.
Who should I call to ask about financial aid or insurance network?
**Emory University Hospital/Winship Cancer Institute Financial Assistance:**
- For financial assistance, including insurance coverage, out-of-pocket obligations, and locating financial coverage options, contact a Financial Counselor at (404) 778-7318.
- For insurance department inquiries or general billing questions, call (404) 727-7551 and press 2.
What insurance does Emory University Hospital/Winship Cancer Institute accept?
Emory University Hospital/Winship Cancer Institute accepts most major insurance plans, including private and employer-based plans, Federal health insurance marketplace plans, traditional Medicare, and Medicare Advantage plans. They will file your insurance claims, both primary and secondary, and offer the services of a Financial Counselor, free of charge, to assist with the financial aspects of cancer treatment. For insurance or billing questions, please call (404) 778-7318, and for more information on accepted insurance plans, contact 404-778-7777 or 1-800-75-EMORY (1-800-753-6679).
What awards or recognition has Emory University Hospital/Winship Cancer Institute received?
Emory University Hospital and Winship Cancer Institute boast Magnet® recognition from the American Nurses Credentialing Center (ANCC), highlighting their excellence in nursing professionalism, teamwork, and patient care. The Emory University School of Medicine is renowned for its significant contributions to medical research, including Dr. Byron Au-Yeung's studies on T cell diversity and Dr. Cassandra Quave's ethnobotany research focusing on antibiotic properties.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.